Cited by 320Treatment of Major DepressionTryptophan and brain disordersNeural and Behavioral Psychology Studies

The DOI matches its Crossref record; 75 of the 79 references it cites were found in a registry or an index; none of the 87 sources its claims cite is checked for support yet.

Cognitive impairment in major depressive disorder

Open access

Abstract

Cognitive dysfunction is a symptomatic domain identified across many mental disorders. Cognitive deficits in individuals with major depressive disorder (MDD) contribute significantly to occupational and functional disability. Notably, cognitive subdomains such as learning and memory, executive functioning, processing speed, and attention and concentration are significantly impaired during, and between, episodes in individuals with MDD. Most antidepressants have not been developed and/or evaluated for their ability to directly and independently ameliorate cognitive deficits. Multiple interacting neurobiological mechanisms (eg, neuroinflammation) are implicated as subserving cognitive deficits in MDD. A testable hypothesis, with preliminary support, posits that improving performance across cognitive domains in individuals with MDD may improve psychosocial function, workplace function, quality of life, and other patient-reported outcomes, independent of effects on core mood symptoms. Herein we aim to (1) provide a rationale for prioritizing cognitive deficits as a therapeutic target, (2) briefly discuss the neurobiological substrates subserving cognitive dysfunction, and (3) provide an update on current and future treatment avenues.

Overview

Integrity signals

Registry

Crossref · 10.1017/s1092852918001207

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

72 Not checked yet · 8 Own interpretation · 1 No basis given

Verify all 87 references — free account
  • It may state two separate claims as one. 11
  • Probably not a substantial claim. 6
  • The quote only partly states this claim. 1
17 of 17
  • The paper relies on this without support.

    Cognitive dysfunction is a core diagnostic criterion of major depressive disorder according to the Research Domain Criteria.

    “Indeed, cognitive dysfunction is well established as a core diagnostic criterion of MDD according to the Research Domain Criteria (RDoC).”
  • The paper relies on this without support.

    A significant subpopulation of individuals with major depressive disorder does not achieve functional remission after treatment with multiple FDA-approved pharmacological agents.

    “A significant subpopulation of individuals with MDD does not achieve functional remission after treatment with multiple FDA-approved pharmacological agents.”
  • The paper relies on this without support.

    Improvements in mood do not necessarily translate into improvements in function.

    “It is important to note that improvements in mood do not necessarily translate into improvements in function.”
  • The paper relies on this without support.

    Domain-specific cognitive deficits in learning and memory, executive function, processing speed, and attention and concentration are highly replicated findings in individuals with major depressive disorder presenting with a major depressive episode.

    “Domain-specific cognitive deficits in learning and memory, executive function, processing speed, and attention and concentration are highly replicated findings in individuals with MDD presenting with a major depressive episode (MDE).”
  • The paper relies on this without support.

    Individuals with major depressive disorder exhibit a bilateral reduction in hippocampal volume.

    “It is recognized that individuals with MDD exhibit a bilateral reduction in hippocampal volume.”
  • The paper relies on this without support.

    The reduction in hippocampal volume is proportional with the frequency of illness episodes.

    “The reduction in hippocampal volume has also been shown to be proportional with the frequency of illness episodes.”
  • The paper relies on this without support.

    Individuals with major depressive disorder exhibit hypoactivity of the prefrontal cortex, which is associated with increased activity of the anterior cingulate cortex.

    “In addition, individuals with MDD exhibit hypoactivity of the prefrontal cortex, which is associated with increase in activity of the ACC.”
  • The paper relies on this without support.

    Current antidepressant regimens do not primarily target psychosocial impairments and workplace disability in major depressive disorder.

    “Despite the foregoing evidence, current antidepressant regimens do not primarily target psychosocial impairments and workplace disability in MDD.”
  • The paper relies on this without support.

    Cognitive disturbances are more commonly observed in individuals with major depressive disorder compared to the general population.

    “Cognitive disturbances are more commonly observed in individuals with MDD compared to the general population.”
  • The paper relies on this without support.

    The specific efficacy of computerized measures of cognitive function in clinical populations remains elusive.

    “Notwithstanding the foregoing evidence, the specific efficacy of computerized measures of cognitive function in clinical populations remains elusive.”
  • The paper relies on this without support.

    Current psychotherapies primarily target hot cognitive deficits, and effective strategies targeting cold cognition still require further investigation.

    “However, current psychotherapies primarily target “hot” cognitive deficits, and therefore effective strategies targeting “cold” cognition still require further investigation.”
  • The paper relies on this without support.

    Brain stimulation therapies are associated with greater tolerability, reduced likelihood of cognitive impairment, and higher rates of remission in treatment-resistant individuals.

    “For example, brain stimulation therapies have been associated with greater tolerability, reduced likelihood of cognitive impairment, and higher rates of remission in treatment-resistant individuals.”
  • The paper relies on this without support.

    Available evidence indicates that improvements in measures of cognitive function with conventional antidepressants are associated with improvements in depressive symptom severity.

    “Available evidence indicates that improvements in measures of cognitive function with the use of conventional antidepressants are associated with improvements in depressive symptom severity.”
  • The paper relies on this without support.

    There is a paucity of FDA-approved pharmacological agents or interventions that are efficacious, tolerable, and specifically target cognitive dysfunction associated with major depressive disorder.

    “There is currently a paucity of FDA-approved pharmacological agents and/or interventions that are efficacious, tolerable, and specifically target cognitive dysfunction associated with MDD.”
  • The paper relies on this without support.

    Incretins may improve cognitive function.

    “Preliminary data suggest that incretins may also improve cognitive function.”
  • The paper relies on this without support.

    Intranasal insulin has cognitive-enhancing effects in MDD.

    “For example, intranasal insulin has been shown to be procognitive in individuals with MDD.”
  • The paper relies on this without support.

    Intranasal insulin's cognitive benefits are greater in MDD patients who also have diabetes or insulin dysregulation.

    “In particular, the procognitive effects of intranasal insulin are stronger in individuals with a history of diabetes and insulin dysregulation comorbid with MDD.”
  • The authors state this as an assumption.

    TNF-α antagonists are an effective add-on for cognitive symptoms in MDD.

    “Treatment with TNF-α antagonists is postulated to be an efficacious adjunctive approach to target cognitive symptoms in individuals with MDD.”
  • The paper relies on this without support.

    In the brain, insulin blocks proapoptotic pathways and is important for neuroplasticity, neurogenesis, and neuronal growth and survival.

    “In the brain, insulin inhibits proapoptotic pathways and plays critical roles in neuroplasticity, neurogenesis, and neuronal growth and survival.”
  • The paper relies on this without support.

    Psychostimulants are prescribed for depressive symptoms in MDD.

    “Psychostimulants have also been used to treat depressive symptoms in individuals with MDD; however, available evidence is mixed.”
  • The paper relies on this without support.

    Available evidence on psychostimulants for depressive symptoms in MDD is mixed.

    “Psychostimulants have also been used to treat depressive symptoms in individuals with MDD; however, available evidence is mixed.”
21 of 21

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 79 references

Cited by

Sorted by citations

See all 320

Metadata

Authors
Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., Fus, D., Subramaniapillai, M., Lee, Y., & McIntyre, R. S.
Affiliations
University Health Network (CA)
Corresponding author
McIntyre, Roger S.
Venue
CNS Spectrums
Published
2018-11-23
Volume
24
Issue
1
Pages
22-29
ISSN
  • 1092-8529 (ISSN-L)
  • 2165-6509
OpenAlex
W2901954088
Cited by
320
References
79
Citations by year
2026: 50 · 2025: 65 · 2024: 80 · 2023: 52 · 2022: 37 · 2021: 26 · 2020: 5 · 2019: 4 · 2018: 1
FWCI
1.05
Type
journal article
Language
en
Open access
Locations
  • CNS Spectrums (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
major depressive disorder, cognitive impairment, learning and memory, executive function, processing speed, attention, antidepressants, neuroinflammation, neurobiological mechanisms, psychosocial functioning, quality of life, treatment goals
MeSH terms
Antidepressive Agents, Cognition, Cognition Disorders, Major Depressive Disorder, Depressive Disorder, Major, Humans, Nootropic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review